Sharma Shatakshi, Kumar Sunil, Sajjad Sheeral, Sharma Samriddhi
Department of Medicine, Datta Meghe Institute of Higher Education and Research, Jawaharlal Nehru Medical College, Wardha, IND.
Cureus. 2023 Mar 23;15(3):e36565. doi: 10.7759/cureus.36565. eCollection 2023 Mar.
Irritable bowel syndrome (IBS) is a persistent set of symptoms that reduces one's goodness of life. The treatment of these people is usually focused on reducing the symptoms caused by the condition. This article examines the function of probiotics in alleviating symptoms in IBS patients. The goal of studying the impact of probiotics on IBS patients is to research the changes they cause to the gut microbiota, which may be beneficial in preventing and treating such diseases over time. This article also discusses the pathophysiology, diagnostic standards, therapeutic modalities, probiotic sources, and therapeutic relevance for IBS patients.
肠易激综合征(IBS)是一组持续存在的症状,会降低患者的生活质量。对这些患者的治疗通常侧重于减轻该病症引起的症状。本文探讨了益生菌在缓解IBS患者症状方面的作用。研究益生菌对IBS患者影响的目的是研究其对肠道微生物群的改变,随着时间的推移,这可能有助于预防和治疗此类疾病。本文还讨论了IBS患者的病理生理学、诊断标准、治疗方式、益生菌来源及治疗意义。